Skip to content
★ Sign in to follow
HL

Henan Lingrui Pharmaceutical Co., Ltd. Stock: price and insider trades · China

羚锐制药

CN·Mcap CN¥12.1BHealth Care

Henan Lingrui Pharmaceutical Co., Ltd.: what insiders have been doing

Henan Lingrui Pharmaceutical Co., Ltd., classified in the Health Care sector, is a listed company. Its insiders report their share dealings to SSE / SZSE (CSRC). No insider at Henan Lingrui Pharmaceutical Co., Ltd. has published a filing in the past twelve months. The most recent one dates from 24 May 2024.

Our records for Henan Lingrui Pharmaceutical Co., Ltd. go back to 2021, with no purchases and 5 sales on the open market in total.

Other companies in the same sector with recent insider buying flagged by our signals: Dynavox Group AB and Vetoquinol SA. This summary is built from SSE / SZSE (CSRC) disclosures alone and does not predict where the share price will go.

Insider Decl.
5
Thresholds
n/a
Buy Volume
n/a
n/a
Sell Volume
€3M
5 ops. · all time

This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.

Fundamental score
Ranked 3,235 of 26,897 companies
72.4
score / 100
Value
58
Quality
87
FCF yld4.1%
Earn yld6.3%
EV/EBITDA12.7x
ROE25%
Gross mgn80%
Net mgn20%
Debt/EBITDA0.4x
Pillars2/3

Transparent value + quality ranking, distinct from the insider signal.

Financial data

as of FY 2025

FY ended December 2025 · cache

CN¥21.29
Analyst consensus
1 analysts
·
CN¥26.20Target CN¥26.20(+23%)CN¥26.20
Income statement
RevenueCN¥3.9B
Gross profitCN¥3.1B80% margin
EBITDACN¥981.9M25% margin
Net incomeCN¥759.5M20.0% margin
Valuation
PER (trailing)15.4x
PER (forward)14.2x
P/Book3.7x
Beta-0.02
Balance sheet & cash
Market capCN¥12.1B
Total debtCN¥398.5M
Free Cash FlowCN¥497.1M
Debt / Equity13%
Profitability & ownership
ROE24.6%
ROA9.4%
% insiders24.0%
% institutions11.4%
Last declaration on 24 May 2024
Declarations5 total
  • ▼
    监事Executives
    1M CNY15SSE
    47,600 shares100.0% of flowA股XSHGSSE:173000007691012130
  • ▼
    董事Executives
    1M CNY15SSE
    80,000 shares95.3% of flowA股XSHGSSE:173000006302345950
  • ▼
    董事Executives
    59,050 CNY7SSE
    5,000 shares4.7% of flowA股XSHGSSE:173000005506994780
  • ▼
    董事长,总裁Executives
    6M CNY25SSE
    527,300 shares29.8% of flowA股XSHGSSE:173000005041325920
  • ▼
    董事长,总裁Executives
    14M CNY29SSE
    1,248,800 shares70.2% of flowA股XSHGSSE:173000005075801470

5 of 5 declarations

About Henan Lingrui Pharmaceutical Co., Ltd.

羚锐制药 is a company operating in the health and pharmaceutical sector, listed on the XSHG market. It focuses on the research, development, and manufacturing of pharmaceutical products.

Recent ranked signals in the same sector

Purchases our model currently ranks for the recommendations list.

All recommendations